University of California Davis Health Pulmonary Disease and Critical Care Medicine

Topics

• Asthma and respiratory diseases 85
• Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 70
• Air Quality and Health Impacts 61
• Chronic Obstructive Pulmonary Disease (COPD) Research 61
• Neuroscience and Neuropharmacology Research 57
• Pulmonary Hypertension Research and Treatments 49
• Advanced Chemical Sensor Technologies 38
• Antioxidant Activity and Oxidative Stress 34
• Respiratory Support and Mechanisms 31
• Obstructive Sleep Apnea Research 27
• Venous Thromboembolism Diagnosis and Management 26
• Cystic Fibrosis Research Advances 23

Most cited

1. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.

   Chest · 2021 · 806 citations · Susan Murin

2. Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.

   The New England journal of medicine · 2021 · 514 citations · Roblee Allen

3. Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.

   Chest · 2021 · 351 citations · Susan Murin

4. Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021.

   Chest · 2024 · 106 citations · Susan Murin

5. Validation of Proposed Criteria for Progressive Pulmonary Fibrosis.

   American journal of respiratory and critical care medicine · 2023 · 127 citations · Janelle Pugashetti, Sahand Ghodrati

6. Evaluation and Management of Adults with Obstructive Sleep Apnea Syndrome.

   Lung · 2021 · 166 citations · Krishna M. Sundar